Gen Matsumoto
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Inhibition of ESCRT-III activates alternative pathways for protein degradation and secretion.
Journal: Neurochemistry international
Published: January 09, 2026
Author Correction: Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Journal: Nature medicine
Published: January 24, 2025
Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool.
Journal: Biophysics and physicobiology
Published: May 17, 2024
α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders.
Journal: Journal of movement disorders
Published: March 22, 2024
Application of single-molecule analysis to singularity phenomenon of cells.
Journal: Biophysics and physicobiology
Published: February 29, 2024
A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology.
Journal: Brain communications
Published: January 18, 2024
Research on the molecular mechanism of singularity phenomenon in neurological disorders.
Journal: Biophysics and physicobiology
Published: December 28, 2023
The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis.
Journal: Scientific reports
Published: June 10, 2023
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Journal: Nature medicine
Published: July 01, 2022
Detection of Prions in a Cadaver for Anatomical Practice.
Journal: The New England journal of medicine
Published: June 08, 2022
Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
Journal: Aging cell
Published: September 06, 2021
Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
Journal: Neuroscience letters
Published: September 07, 2018
Last Updated: 09/26/2026